EMA Approves Ocular Formulation of Bevacizumab EMA Approves Ocular Formulation of Bevacizumab

Europe has approved the use of monoclonal antibody bevacizumab for the treatment of neovascular age-related macular degeneration.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Ophthalmology Source Type: news